Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-24-004413

Chief Executive Officer acquired 3,317 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nijhawan Pardeep · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-01 Grant or award : show line 1 in the form +3,317 126,263 D
Loading xslF345X05/ownership.xml…